跳至主要内容
临床试验/EUCTR2012-001541-40-NL
EUCTR2012-001541-40-NL进行中(未招募)不适用

Effect of Carbon Dioxide Enriched Ambient Air on Pharmacokinetics and Deposition In Bronchiectasis Patients Using Tobramycin Inhalation: A proof of concept study.

Vu University Medical Center0 个研究点开始时间: 2012年7月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Bronchiectasis
  • Antibiotic inhalation treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 11
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 3
  • Bronchiectasis
  • Antibiotic inhalation treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 11
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 3

排除标准

  • oAge <21 years.
  • oChronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
  • oRenal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
  • oNeuromuscular diseases.
  • oImpaired hearing
  • oPregnant or breastfeeding.
  • oBronchiectasis exacerbation during last 4 weeks.
  • oHistory of panic attacks
  • oAge <21 years.
  • oChronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
  • oRenal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
  • oNeuromuscular diseases.
  • oImpaired hearing
  • oPregnant or breastfeeding.
  • oBronchiectasis exacerbation during last 4 weeks.
  • oHistory of panic attacks

研究者

发起方
Vu University Medical Center

相似试验

The effect of carbon dioxide on inhaled antibiotics... | 临床试验